Drug Trial Radar · NCT02886728
Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy
Last checked: Nov 19, 2026Latest source record: Jun 1, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,252
Actual
Start
Aug 8, 2016
Primary completion
Oct 5, 2018
Study completion May 8, 2019
Sponsor
- Lead sponsor
- Gilead SciencesGilead Sciences (GILD)
- Sponsor type
- Industry
- Collaborators
- Lakefront Biotherapeutics NV
- First posted
- Sep 1, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the effects of filgotinib in combination with methotrexate (MTX) versus MTX alone in adults with active rheumatoid arthritis (RA).
Conditions
- Rheumatoid Arthritis
Interventions
FilgotinibDrug
Tablet(s) administered orally once daily
Placebo to match filgotinibDrug
Tablet(s) administered orally once daily
MTXDrug
Capsule(s) administered orally once weekly
Placebo to match MTXDrug
Capsule(s) administered orally once weekly
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Achieved an American College of Rheumatology (ACR) 20% Improvement (ACR20) Response at Week 24Time frame: Week 24
Locations
186 sites in 31 countries. Site status is shown where the registry gives one.
Site not named
Huntsville, Alabama
Site not named
Phoenix, Arizona
Site not named
Tucson, Arizona
Site not named
Covina, California
Site not named
Los Angeles, California
Site not named
Palm Desert, California
Site not named
Victorville, California
Site not named
Whittier, California
Site not named
DeBary, Florida
Site not named
Jacksonville, Florida
Site not named
Miami, Florida
Site not named
Orlando, Florida
Site not named
Plantation, Florida
Site not named
Springfield, Illinois
Site not named
Wichita, Kansas
Site not named
Elizabethtown, Kentucky
Site not named
Cumberland, Maryland
Site not named
Wheaton, Maryland
Site not named
Worcester, Massachusetts
Site not named
Saint Clair Shores, Michigan
Site not named
Eagan, Minnesota
Site not named
Hattiesburg, Mississippi
Site not named
Tupelo, Mississippi
Site not named
St Louis, Missouri
Site not named
Lincoln, Nebraska
Site not named
Lebanon, New Hampshire
Site not named
Freehold, New Jersey
Site not named
Toms River, New Jersey
Site not named
Albuquerque, New Mexico
Site not named
Charlotte, North Carolina
Site not named
Oklahoma City, Oklahoma
Site not named
Tulsa, Oklahoma
Site not named
Bethlehem, Pennsylvania
Site not named
Duncansville, Pennsylvania
Site not named
Wyomissing, Pennsylvania
Site not named
Charleston, South Carolina
Site not named
Orangeburg, South Carolina
Site not named
Memphis, Tennessee
Site not named
Beaumont, Texas
Site not named
Carrollton, Texas
Showing 40 of 186 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.